MedBlog

Taking aim at graft-versus-host disease after stem cell transplant

UT Southwestern explains graft-versus-host disease (GVHD), a potentially serious complication that can occur after an allogeneic stem cell or bone marrow transplant.

Julio Alvarenga Thiebaud, M.D.

April 22, 2024

Ortho-oncology: Improving care for patients with metastatic bone disease

Metastatic bone disease patients find hope with orthopaedic surgery options to decrease fracture risk, improve mobility, and manage pain. UT Southwestern discusses treatment advances and paradigm shifts over the last decade.

Alexandra Callan, M.D.

May 17, 2023

AL amyloidosis treatments offer patients hope and potentially a cure

A new, FDA-approved four-drug combo for AL amyloidosis is improving longevity and quality of life dramatically. UT Southwestern discusses how the medication and a multidisciplinary team of experts can give patients longer, healthier lives.

August 19, 2021

New drugs for cardiac amyloidosis provide hope for patients

For decades, there were no FDA-approved treatments for cardiac amyloidosis in the U.S. But in the last two years, two new therapies were approved for cardiac- and nerve-related ATTR. In this week's MedBlog, UT Southwestern discusses these therapies and what they mean for North Texas patients.

Justin Grodin, M.D., M.P.H.

July 31, 2019